Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Revenue

Harmony Biosciences Holdings had revenue of $215.39M in the quarter ending March 31, 2026, with 16.59% growth. This brings the company's revenue in the last twelve months to $899.11M, up 20.71% year-over-year. In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth.

• Revenue (ttm): $899.11M
• Revenue Growth: +20.71%
• P/S Ratio: 2.28
• Revenue / Employee: $3,068,625
• Employees: 293
• Market Cap: 2.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	868.45M	153.72M	21.51%
Dec 31, 2024	714.73M	132.71M	22.80%
Dec 31, 2023	582.02M	144.17M	32.93%
Dec 31, 2022	437.86M	132.42M	43.35%
Dec 31, 2021	305.44M	145.70M	91.21%
Dec 31, 2020	159.74M	153.75M	2,564.59%
Dec 31, 2019	6.00M	-	-
Dec 31, 2018	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error